Utility of recombinant envelope domain III as a diagnostic antigen for the specific detection of Kyasanur Forest Disease

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text

The study investigated whether a Kyasanur Forest Disease Virus (KFDV) envelope protein fragment, specifically envelope domain III (EDIII), could serve as a more specific diagnostic antigen to detect KFD and reduce delays associated with current non-specific IgM-ELISA and confirmatory RT-PCR. The authors cloned and expressed recombinant KFDV EDIII and non-structural protein 1 (NS1) in E. coli, raised polyclonal rabbit antibodies, and found high antibody titers, with no cross-reactivity to dengue virus EDIII/NS1. Using anti-rEDIII polyclonal antibodies, they developed a sandwich ELISA that showed high specificity and sensitivity, and they also used the antibodies to detect the native full-length KFDV-E protein expressed in mammalian cells. The paper does not describe any explicit diagnostic performance limitations or caveats beyond the stated specificity assessment. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Kyasanur Forest Disease (KFD), commonly known as “monkey fever,” is a highly neglected tropical disease caused by the Kyasanur Forest Disease Virus (KFDV). KFD is endemic to Western Ghats of Karnataka, India, with seasonal outbreaks during December to June every year. As there is no standard treatment regime, KFD can be fatal with a mortality rate of 2-10%. Currently, KFD is detected through a non-specific IgM-ELISA followed by RT-PCR, which often delays diagnosis, leading to increased disease severity and even death. To address this, we focused on developing a specific antigen-based KFD detection. The KFDV Envelope Domain III (EDIII) and Non-Structural 1 (NS1) proteins were chosen as detection markers, cloned, and expressed using pET28a(+) vector in BL-21 (Rosetta) E. coli and purified. These proteins were used to raise polyclonal antibodies in rabbits and the antibody titre was found to be 1:256,000 and 1:512,000 against rEDIII and rNS1 proteins, respectively. Importantly, these polyclonal antibodies showed no cross-reactivity against corresponding dengue virus EDIII and NS1 proteins. Using polyclonal antibodies against rEDIII, we developed sandwich ELISA for the specific detection of KFD, which has demonstrated high specificity and sensitivity. Further, anti-rEDIII polyclonal antibodies also detected full-length KFDV-E protein expressed in mammalian cells, confirming the antibody specificity for the native viral antigen.
Full text 1,534 characters · extracted from oa-doi-fallback · click to expand
Abstract Kyasanur Forest Disease (KFD), commonly known as “monkey fever,” is a highly neglected tropical disease caused by the Kyasanur Forest Disease Virus (KFDV). KFD is endemic to Western Ghats of Karnataka, India, with seasonal outbreaks during December to June every year. As there is no standard treatment regime, KFD can be fatal with a mortality rate of 2-10%. Currently, KFD is detected through a non-specific IgM-ELISA followed by RT-PCR, which often delays diagnosis, leading to increased disease severity and even death. To address this, we focused on developing a specific antigen-based KFD detection. The KFDV Envelope Domain III (EDIII) and Non-Structural 1 (NS1) proteins were chosen as detection markers, cloned, and expressed using pET28a(+) vector in BL-21 (Rosetta) E. coli and purified. These proteins were used to raise polyclonal antibodies in rabbits and the antibody titre was found to be 1:256,000 and 1:512,000 against rEDIII and rNS1 proteins, respectively. Importantly, these polyclonal antibodies showed no cross-reactivity against corresponding dengue virus EDIII and NS1 proteins. Using polyclonal antibodies against rEDIII, we developed sandwich ELISA for the specific detection of KFD, which has demonstrated high specificity and sensitivity. Further, anti-rEDIII polyclonal antibodies also detected full-length KFDV-E protein expressed in mammalian cells, confirming the antibody specificity for the native viral antigen. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-05T02:00:03.366016+00:00